snabelen.no

Anti. 🐘· A treatment for cats with a <a href="https://chaos.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener" target="_blank">#COVID19</a>-related infection may help advance <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCOVID</a> research · The supplement Oxaloacetate may help reduce fatigue for LC, but it “did not reach statistical significance,” according to a new study at Bateman Horne Center · A new prospective cohort study in JAMA Oncology of 1,572 participants with cancer found that COVID-19 had a “significant impact” on these patients, incl. hospitalization, treatment disruptions, death<a href="https://thesicktimes.org/2025/07/22/research-updates-july-22/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/07/22/research-updates-july-22/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a>

Anti. 🐘· A new study in PNAS found elevated oxidative stress was a shared characteristic in both <a href="https://chaos.social/tags/MECFS" class="mention hashtag" rel="nofollow noopener" target="_blank">#MECFS</a> and <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCOVID</a> · RECOVER-Treating Long COVID, the clinical trials initiative run by the Foundation for the NIAID, has announced that it will hold a second annual hybrid workshop discussing the initiative’s research · A clinical trial in the U.K. called PHOSP-I is recruiting to test the monoclonal antibody Tocilizumab<a href="https://thesicktimes.org/2025/07/15/research-updates-july-15/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/07/15/research-updates-july-15/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a> <a href="https://chaos.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener" target="_blank">#COVID19</a>

Anti. 🐘· The biotech company Invivyd, which makes the <a href="https://chaos.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener" target="_blank">#COVID19</a> monoclonal antibody Pemgarda, announced that it has launched the SPEAR Study Group to explore the drug for <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCOVID</a> and post-vaccine syndrome (PVS) · A new study from Taiwan published in Pediatrics and Neonatology found about 14% of children developed Long COVID after being infected with <a href="https://chaos.social/tags/SarsCoV2" class="mention hashtag" rel="nofollow noopener" target="_blank">#SarsCoV2</a> · A new observational study is investigating the relationship between COVID-19 and <a href="https://chaos.social/tags/Diabetes" class="mention hashtag" rel="nofollow noopener" target="_blank">#Diabetes</a><a href="https://thesicktimes.org/2025/07/08/research-updates-july-8/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/07/08/research-updates-july-8/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a>

Anti. 🐘· Scientists found a new antiviral drug prototype that prevented Long COVID in mice and could also help treat the disease · A recent preprint shared in medRxiv found further evidence of brain damage after COVID-19 · A new clinical trial for myalgic encephalomyelitis (ME) is recruiting in Tokyo, Japan, to test the monoclonal antibody Rituximab<a href="https://thesicktimes.org/2025/07/01/research-updates-july-1/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/07/01/research-updates-july-1/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a> <a href="https://chaos.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener" target="_blank">#COVID19</a>

Anti. 🐘· A new review paper published in Psychiatry and Clinical Neurosciences focuses on how Long COVID impacts the nervous and immune systems · Another study has found potential biomarkers in the blood of people with myalgic encephalomyelitis (ME) · The Patient-Led Research Collaborative (PLRC) launched a new clinical trial and research study platform for Long COVID and associated diseases: the PLRC Registry<a href="https://thesicktimes.org/2025/06/24/research-updates-june-24/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/06/24/research-updates-june-24/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a> <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCOVID</a> <a href="https://chaos.social/tags/MECFS" class="mention hashtag" rel="nofollow noopener" target="_blank">#MECFS</a>

Anti. 🐘self-harm

Anti. 🐘· Three recent studies show the harmful effects of misdiagnosis for chronic diseases and conditions · A new preprint shared in Research Square found a connection between post-exertional malaise (PEM) and microclots, or tiny blood clots that disrupt how oxygen moves through the body · The Cohen Center for Recovery from Complex Chronic Illness (CoRE) at Mount Sinai in New York is now recruiting for their rapamycin clinical trial for <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCOVID</a> <a href="https://thesicktimes.org/2025/06/10/research-updates-june-10/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/06/10/research-updates-june-10/</a><a href="https://chaos.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener" target="_blank">#COVID19</a> <a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a>

Anti. 🐘· New NIH study found that around one in seven children under age six with a prior SARS-CoV-2 infection met the probable diagnostic criteria for <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCOVID</a> · Pemivibart (Pemgarda), a monoclonal antibody that helps prevent COVID-19, was found to be “well tolerated” and effective in phase 3 clinical trial · New preprint from researchers in the US & Canada used a model called “Mobius” to classify ME & Long COVID with 97% accuracy, using data from blood<a href="https://thesicktimes.org/2025/06/03/research-updates-june-3/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/06/03/research-updates-june-3/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a>

Anti. 🐘· A large study in Nature Genetics found a genetic risk factor for developing <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCOVID</a> · Leading Long COVID and myalgic encephalomyelitis (ME) researchers have pushed back against an op-ed commissioned by the BMJ that spread false claims about <a href="https://chaos.social/tags/MECFS" class="mention hashtag" rel="nofollow noopener" target="_blank">#MECFS</a> · RECOVER-Treating Long COVID (TLC), the clinical trials initiative from the National Institutes of Health’s flagship Long COVID research program, shared updates about forthcoming trials<a href="https://thesicktimes.org/2025/05/27/research-updates-may-27/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/05/27/research-updates-may-27/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a> <a href="https://chaos.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener" target="_blank">#COVID19</a>

Kai ArzheimerThe Spring 2025 Radical Right Bibliography is out 📚 with 180 new entries, now totaling over 1,600 resources on far-right politics. Key topics include economic insecurity, cultural backlash, and leadership. 🔍✨ <a href="https://fediscience.org/tags/RadicalRight" class="mention hashtag" rel="nofollow noopener" target="_blank">#RadicalRight</a> <a href="https://fediscience.org/tags/PoliticalScience" class="mention hashtag" rel="nofollow noopener" target="_blank">#PoliticalScience</a> <a href="https://fediscience.org/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a> <a href="https://www.kai-arzheimer.com/may-is-the-new-april-the-spring-2025-update-of-the-radical-right-bibliography/" rel="nofollow noopener" translate="no" target="_blank">https://www.kai-arzheimer.com/may-is-the-new-april-the-spring-2025-update-of-the-radical-right-bibliography/</a>

Anti. 🐘· <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCOVID</a> clinical trial assessing the monoclonal antibody AER002 found no difference between those who got the drug and placebo· prospective study in Pediatric International found that, six months after SARS-C0V-2 infection, 23% of children had Long COVID symptoms· Chinese study of five participants with Long COVID and myocarditis found severe damage in the mitochondria<a href="https://thesicktimes.org/2025/05/20/research-updates-may-20/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/05/20/research-updates-may-20/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a> <a href="https://chaos.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener" target="_blank">#COVID19</a>

Anti. 🐘· The Bateman Horne Center and Open Medicine Foundation recently released a highly anticipated ME and Long COVID clinical care guide. · Researchers estimate a higher rate of new-onset diabetes after SARS-C0V-2 infection in a systematic review in Emerging Microbes and Infections · A new preprint in Medxriv further demonstrates that Long COVID and ME are not deconditioning.<a href="https://thesicktimes.org/2025/05/13/research-updates-may-13/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/05/13/research-updates-may-13/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a> <a href="https://chaos.social/tags/TheSickTimes" class="mention hashtag" rel="nofollow noopener" target="_blank">#TheSickTimes</a>

Anti. 🐘· Researchers state that post-vaccine syndrome is characterized by persistent immune dysregulation & issues with blood coagulation.· A drug called dapagliflozin, used to treat Type 2 Diabetes, is being investigated for <a href="https://chaos.social/tags/LongCOVID" class="mention hashtag" rel="nofollow noopener" target="_blank">#LongCOVID</a> in a clinical trial.· A double-blind clinical trial is evaluating an experimental drug called REGN7544 for people with postural orthostatic tachycardia syndrome (POTS).<a href="https://thesicktimes.org/2025/05/06/research-updates-may-6/" rel="nofollow noopener" translate="no" target="_blank">https://thesicktimes.org/2025/05/06/research-updates-may-6/</a><a href="https://chaos.social/tags/ResearchUpdate" class="mention hashtag" rel="nofollow noopener" target="_blank">#ResearchUpdate</a>

Nylige søk

Alternativer for søk

Administrert av:

Serverstatistikk:

#researchupdate